December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bilibili Inc ADR (NQ: BILI )

122.63 USD -0.59 (-0.48%)
Official Closing Price Updated: 7:59 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bilibili Inc ADR

< Previous 1 2 Next >
Thinking about trading options or stock in Plug Power, Pfizer, Carnival Corp, American Airlines, or Bilibili?
InvestorsObserver issues critical PriceWatch Alerts for PLUG, PFE, CCL, AAL, and BILI. 
From PR Newswire
Qiming Venture Partners' Portfolio Company APT Medical Listed on STAR Board of Shanghai Stock Exchange
Qiming Venture Partners' portfolio company APT Medical (SHSE: 688617) today successfully listed on the Science and Technology Innovation Board (the STAR Board) of Shanghai Stock Exchange. The issue... 
From PR Newswire
Thinking about trading options or stock in General Electric, Celsius Holdings, American Airlines, Bilibili, or Visa?
InvestorsObserver issues critical PriceWatch Alerts for GE, CELH, AAL, BILI, and V. 
From PR Newswire
Thinking about buying stock in Moderna, Alibaba, Exxon Mobil, Bilibili Inc, or BioNTech?
InvestorsObserver issues critical PriceWatch Alerts for MRNA, BABA, XOM, BILI, and BNTX. 
From PR Newswire
Qiming's Portfolio Company Antengene Lists on Main Board of HKEX
Qiming's portfolio company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited today. The issue price is HK$18.08 per share; the stock opens at HK$... 
From PR Newswire
Bilibili Inc. Announces Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
Qiming Venture Partners Announces Final Closing of US$ 1.2 Billion Fund VII
Fund targets early stage healthcare and technology investments 
From PR Newswire
Bilibili to Report Third Quarter 2020 Financial Results on Wednesday, November 18, 2020
-Earnings Call Scheduled for 8:00 p.m. ET on November 18, 2020- 
From GlobeNewswire News Releases
Qiming's Portfolio Company Zai Lab Lists on Main Board of HKEX
Qiming's portfolio company Zai Lab (SEHK:9688, NASDAQ:ZLAB), an innovative commercial-stage biopharmaceutical company, officially listed on the Main Board of The Stock Exchange of Hong Kong Limited... 
From PR Newswire
Bilibili Announces Equity Investment in Huanxi Media
From GlobeNewswire News Releases
Bilibili Inc. Announces Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
Bilibili to Report Second Quarter 2020 Financial Results on Wednesday, August 26, 2020
-Earnings Call Scheduled for 9:00 p.m. ET on August 26, 2020- 
From GlobeNewswire News Releases
Bilibili Announces Three-Year Strategic Partnership with Riot Games for Live Broadcasting League of Legend Events in China
From GlobeNewswire News Releases
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
From ACN Newswire
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization
Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class... 
From PR Newswire
Thinking about trading options or stock in Tesla, Overstock.com, Bilibili Inc, Carnival Corp, or American Airlines?
InvestorsObserver issues critical PriceWatch Alerts for TSLA, OSTK, BILI, CCL, and AAL. 
From PR Newswire
Qiming's Portfolio Company Gan & Lee Pharmaceuticals Lands A-Shares Main Board
Chinese insulin manufacturer Gan & Lee Pharmaceuticals (SHSE: 603087), Qiming's portfolio company today lands on the A-shares main board market. The issue price of Gan & Lee is RMB 63.32 per share. The... 
From PR Newswire
Qiming's Portfolio Company SinocellTech Lands on STAR Market
Chinese biologic drug developer SinocellTech, Qiming's portfolio company, today lands on the Science and Technology Innovation Board (the STAR Market). The issue price of SinocellTech (SHSE: 688520) is... 
From PR Newswire
Bilibili Inc. Announces Completion of Convertible Senior Notes
From GlobeNewswire News Releases
Bilibili Inc. Prices Offering of Convertible Senior Notes
From GlobeNewswire News Releases
Bilibili Inc. Announces Proposed Offering of US$650 Million Convertible Senior Notes
From GlobeNewswire News Releases
Bilibili Announces Changes to Board and Committee Compositions
From GlobeNewswire News Releases
Bilibili Inc. Announces First Quarter 2020 Financial Results
From GlobeNewswire News Releases
Bilibili to Report First Quarter 2020 Financial Results on Monday, May 18, 2020
-Earnings Call Scheduled for 9:00 p.m. ET on May 18, 2020- 
From GlobeNewswire News Releases
Qiming's Nisa Leung and Duane Kuang Named on 2020 Forbes Midas List
Forbes today released the 2020 Midas List, a ranking of the world's top 100 venture capitalists. Nisa Leung and Duane Kuang, Managing Partners of Qiming Venture Partners, ranked at No.33 and No.69 on... 
From PR Newswire
Sony Announces Investment in the Chinese Entertainment Platform Bilibili Inc.
Sony Corporation ("Sony") today announced that Sony Corporation of America ("SCA"), a wholly-owned subsidiary of Sony, has entered into a definitive agreement, pursuant to which SCA will subscribe for... 
From PR Newswire
Bilibili Announces Equity Investment from Sony
From GlobeNewswire News Releases
Qiming Venture Partners Raises $1.1 Billion Fund VII
Fund targets early stage healthcare and technology investments 
From PR Newswire
Thinking about buying stock in Bilibili, BP, Diffusion Pharmaceuticals, Kinder Morgan, or Rite Aid?
InvestorsObserver issues critical PriceWatch Alerts for BILI, BP, DFFN, KMI, and RAD. 
From PR Newswire
Bilibili Files Its Annual Report on Form 20-F
From GlobeNewswire News Releases
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.